Bryce Andrew Crocker - Net Worth and Insider Trading
Bryce Andrew Crocker Net Worth
The estimated net worth of Bryce Andrew Crocker is at least $13 Million dollars as of 2024-11-12. Bryce Andrew Crocker is the Director, Senior Officer of Knight Therapeutics Inc and owns about 2,500,000 shares of Knight Therapeutics Inc (TSX:GUD) stock worth over $13 Million. Bryce Andrew Crocker is also the Director, Senior Officer of Jervois Global Ltd and owns about -2,260,331 shares of Jervois Global Ltd (TSXV:JRV) stock worth over $-22,603. Details can be seen in Bryce Andrew Crocker's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bryce Andrew Crocker has not made any transactions after 2022-11-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Bryce Andrew Crocker
Bryce Andrew Crocker Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bryce Andrew Crocker owns 2 companies in total, including Knight Therapeutics Inc (TSX:GUD) , and Jervois Global Ltd (TSXV:JRV) .
Click here to see the complete history of Bryce Andrew Crocker’s form 4 insider trades.
Insider Ownership Summary of Bryce Andrew Crocker
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2019-07-25 | Director & Senior Officer |
| TSXV:JRV | Jervois Global Ltd | 2022-11-30 | Director & Senior Officer |
Bryce Andrew Crocker Latest Holdings Summary
Bryce Andrew Crocker currently owns a total of 2 stocks. Among these stocks, Bryce Andrew Crocker owns 2,500,000 shares of Knight Therapeutics Inc (TSX:GUD) as of July 25, 2019, with a value of $13 Million and a weighting of 100.18%. Bryce Andrew Crocker also owns -2,260,331 shares of Jervois Global Ltd (TSXV:JRV) as of November 30, 2022, with a value of $-22,603 and a weighting of -0.18%.
Latest Holdings of Bryce Andrew Crocker
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2019-07-25 | 2,500,000 | 5.17 | 12,925,000 |
| TSXV:JRV | Jervois Global Ltd | 2022-11-30 | -2,260,331 | 0.01 | -22,603 |
Holding Weightings of Bryce Andrew Crocker
Bryce Andrew Crocker Form 4 Trading Tracker
According to the SEC Form 4 filings, Bryce Andrew Crocker has made a total of 0 transactions in Knight Therapeutics Inc (TSX:GUD) over the past 5 years. The most-recent trade in Knight Therapeutics Inc is the acquisition of 1,500,000 shares on July 25, 2019, which cost Bryce Andrew Crocker around $11 Million.
According to the SEC Form 4 filings, Bryce Andrew Crocker has made a total of 1 transactions in Jervois Global Ltd (TSXV:JRV) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Jervois Global Ltd is the sale of 4,760,331 shares on November 30, 2022, which brought Bryce Andrew Crocker around $2 Million.
Insider Trading History of Bryce Andrew Crocker
- 1
Bryce Andrew Crocker Trading Performance
GuruFocus tracks the stock performance after each of Bryce Andrew Crocker's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bryce Andrew Crocker is 13.29%. GuruFocus also compares Bryce Andrew Crocker's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bryce Andrew Crocker within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Bryce Andrew Crocker's insider trading performs compared to the benchmark.
Performance of Bryce Andrew Crocker
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.09 | | | | | |
| Relative Return to S&P 500(%) | 8.3 | | | | | |
Bryce Andrew Crocker Ownership Network
Ownership Network List of Bryce Andrew Crocker
Ownership Network Relation of Bryce Andrew Crocker
Bryce Andrew Crocker Owned Company Details
What does Knight Therapeutics Inc do?
Who are the key executives at Knight Therapeutics Inc?
Bryce Andrew Crocker is the Director & Senior Officer of Knight Therapeutics Inc. Other key executives at Knight Therapeutics Inc include Director & Senior Officer Samira Sakhia , Senior Officer Amal Khouri , and Director & Director or Senior Officer of 10% Security Holder Jonathan Ross Goodman .
Knight Therapeutics Inc (TSX:GUD) Insider Trades Summary
Over the past 18 months, Bryce Andrew Crocker made no insider transaction in Knight Therapeutics Inc (TSX:GUD). Other recent insider transactions involving Knight Therapeutics Inc (TSX:GUD) include a net purchase of 674,800 shares made by Sime Armoyan , a net sale of 65,000 shares made by Amal Khouri , and a net sale of 45,000 shares made by Robert Nathaniel Lande .
In summary, during the past 3 months, insiders sold 20,100 shares of Knight Therapeutics Inc (TSX:GUD) in total and bought 20,000 shares, with a net sale of 100 shares. During the past 18 months, 314,200 shares of Knight Therapeutics Inc (TSX:GUD) were sold and 949,000 shares were bought by its insiders, resulting in a net purchase of 634,800 shares.
Knight Therapeutics Inc (TSX:GUD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Knight Therapeutics Inc Insider Transactions
Bryce Andrew Crocker Mailing Address
Above is the net worth, insider trading, and ownership report for Bryce Andrew Crocker. Currently GuruFocus does not have mailing address information for Bryce Andrew Crocker.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
